Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1
about
Regulation of acidification and apoptosis by SHP-1 and Bcl-2Identification and characterization of leukocyte-associated Ig-like receptor-1 as a major anchor protein of tyrosine phosphatase SHP-1 in hematopoietic cellsA protein-arginine methyltransferase binds to the intracytoplasmic domain of the IFNAR1 chain in the type I interferon receptorIdentification of major binding proteins and substrates for the SH2-containing protein tyrosine phosphatase SHP-1 in macrophagesInterferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis CAntiviral actions of interferonsDirect association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1Structure-guided studies of the SHP-1/JAK1 interaction provide new insights into phosphatase catalytic domain substrate recognitionSHP1 protein-tyrosine phosphatase regulates HoxA10 DNA binding and transcriptional repression activity in undifferentiated myeloid cellsArginine methylation of STAT1 regulates its dephosphorylation by T cell protein tyrosine phosphatasePhosphotyrosine 1173 mediates binding of the protein-tyrosine phosphatase SHP-1 to the epidermal growth factor receptor and attenuation of receptor signalingSLP-76 is a direct substrate of SHP-1 recruited to killer cell inhibitory receptorsSTAT3 as a therapeutic target in head and neck cancerExogenous gamma and alpha/beta interferon rescues human macrophages from cell death induced by Bacillus anthracisSHP-1 regulation of p62(DOK) tyrosine phosphorylation in macrophagesShp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathwayProtein tyrosine phosphatases in the JAK/STAT pathwayInterferon-alpha-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinaseRegulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1Interferon type I signaling pathwaysBeta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway.Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyperresponsiveness.Activation of a protein tyrosine phosphatase and inactivation of Raf-1 by somatostatinSHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cells.A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-alpha signaling.Activation of Cdk2 stimulates proteasome-dependent truncation of tyrosine phosphatase SHP-1 in human proliferating intestinal epithelial cells.Negative regulation of the JAK/STAT pathway.Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents.Pancreatic T cell protein-tyrosine phosphatase deficiency ameliorates cerulein-induced acute pancreatitis.Negative signaling in health and disease.Protein kinase A-mediated inhibition of gamma interferon-induced tyrosine phosphorylation of Janus kinases and latent cytoplasmic transcription factors in human monocytes by Ehrlichia chaffeensis.Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.Leishmania interferes with host cell signaling to devise a survival strategy.Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy.Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factorCentral neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1.The tyrosine 343 residue of nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) is important for its interaction with SHP1, a cytoplasmic tyrosine phosphatase with tumor suppressor functions.Identification and characterization of S2V, a novel putative siglec that contains two V set Ig-like domains and recruits protein-tyrosine phosphatases SHPs.The molecular regulation of Janus kinase (JAK) activationJanus kinases: components of multiple signaling pathways.
P2860
Q22010599-A708D090-A8F5-4020-99DB-D9D15E0DB0BFQ22253887-04348C78-3AB2-4D31-B421-D0D3B560DFB9Q24319127-7B46CC83-1E33-4283-B49E-7D3071E1CB29Q24522530-AFBEDE2D-8D02-4DA0-A0D3-448EFF1F57A3Q24530717-21F35B1D-D248-4738-9DCD-3927C6DDD2F1Q24550676-AF0F116D-6020-4C62-8611-94B132232CBAQ24647567-2264D585-A5E6-464E-B7AA-E8EE1DCE2C23Q27675796-8BF9FD28-448A-49F3-B9AE-E0E1A0656659Q28216204-E176061B-AAF5-4DBD-8626-1B48604C2556Q28217313-B996E010-CC5A-4E5B-831F-FCB17F6310D1Q28282019-012B02CE-D14E-49F0-99D4-600FFA12A3E8Q28284908-DAD2C402-38D4-4067-8F3F-335464ED1915Q28299368-532F2B49-D329-460F-90BA-8CEF020945F7Q28393848-DAE13048-61F2-4F77-AF35-6D99395C8573Q28593535-370EABEF-66EE-44D4-85A5-9925C11E53D9Q28609398-EBD20BA4-061D-437D-8485-1373ACBD8FA4Q28646447-DA61CF51-3814-4382-A00D-58F1108DCC2FQ28646526-02513C95-6539-48D6-8EE8-E0D28A71386BQ30176913-A06DC6CF-6C12-4539-8F80-0292EAE1BB8BQ30230895-C370EFCA-3DAF-4559-B56F-DFF31A3632C6Q30452664-0BCC673A-3C4B-40F9-8AEB-E5666349BBEBQ30453894-4AFB5C2B-D829-4877-84AB-32A0FD7D6508Q30468565-93E05530-990C-4E75-8478-8A9E4EA9BF64Q30536340-4F809A0A-2C8F-4936-AA1D-E958033F4E30Q31794325-152D94BE-C7A9-4B1A-AE54-AED698B7F1D3Q33350768-E773892D-6552-4124-8481-7F2B296CEC67Q33539658-D0E14757-8F72-48BE-860F-DF8AAA9D9F59Q33565239-26803423-382C-438E-87A7-065E9CBB1A84Q33592510-7E2C6BB3-699F-478C-830A-4D79535155BAQ33664134-C49AED86-D251-435E-9BEA-277B8FBA1D6AQ33754324-41A54811-17C7-4B97-AC9E-503DDDDCADDDQ33755221-7DD344F2-95B2-4480-BDF4-C0EC624171C8Q33781265-FE84DFDE-F2BA-4861-B6C5-CD163296BEADQ33838824-547E3D02-0FBC-467C-80D0-E1727197B06BQ33901975-7EEEDF2E-24A8-43D1-9E9E-3A0374371A2DQ33905233-B586F2C2-190D-457F-A76B-61B1CD78FC98Q33924261-1A93BA23-1E2C-4E85-9FFC-15C834D0E4CBQ33944757-07625171-8575-4C6F-917E-E79088A5B0DAQ33956113-EABCB972-5C82-4D39-97B9-9AAE3C82A168Q34103659-F80C685A-AEAF-4EA6-A745-69301B5268D5
P2860
Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1
description
1995 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1995
@ast
im Dezember 1995 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1995/12/01)
@sk
vědecký článek publikovaný v roce 1995
@cs
wetenschappelijk artikel (gepubliceerd op 1995/12/01)
@nl
наукова стаття, опублікована в грудні 1995
@uk
مقالة علمية (نشرت في ديسمبر 1995)
@ar
name
Differential regulation of the ...... ng tyrosine phosphatase SHPTP1
@ast
Differential regulation of the ...... ng tyrosine phosphatase SHPTP1
@en
Differential regulation of the ...... ng tyrosine phosphatase SHPTP1
@nl
type
label
Differential regulation of the ...... ng tyrosine phosphatase SHPTP1
@ast
Differential regulation of the ...... ng tyrosine phosphatase SHPTP1
@en
Differential regulation of the ...... ng tyrosine phosphatase SHPTP1
@nl
prefLabel
Differential regulation of the ...... ng tyrosine phosphatase SHPTP1
@ast
Differential regulation of the ...... ng tyrosine phosphatase SHPTP1
@en
Differential regulation of the ...... ng tyrosine phosphatase SHPTP1
@nl
P2093
P2860
P356
P1476
Differential regulation of the ...... ng tyrosine phosphatase SHPTP1
@en
P2093
P2860
P304
P356
10.1128/MCB.15.12.7050
P407
P577
1995-12-01T00:00:00Z